Loading clinical trials...
Loading clinical trials...
This study aims to evaluate the efficacy and safety of Elevvo AudiStim, a sleep auditory stimulation device, as a symptomatic treatment for patients with amnestic mild cognitive impairment (aMCI).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bitbrain
Collaborators
NCT07652775 · Mild Cognitive Impairment (MCI), Depressive Symptoms
NCT07286448 · Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)
NCT07101380 · Mild Cognitive Impairment (MCI)
NCT06669546 · Cognitive Decline, Alzheimer Disease, and more
NCT06962111 · Dementia, Mild Cognitive Impairment (MCI), and more
Bit&Brain Technologies SL
Zaragoza, Zaragoza
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions